NFL BIOSCIENCES SA (ALNFL.PA) Stock Fundamental Analysis

Europe • Euronext Paris • EPA:ALNFL • FR0014003XT0

1.178 EUR
+0.01 (+0.86%)
Last: Feb 10, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

2

Overall ALNFL gets a fundamental rating of 2 out of 10. We evaluated ALNFL against 81 industry peers in the Biotechnology industry. ALNFL scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALNFL is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year ALNFL has reported negative net income.
  • ALNFL had negative earnings in each of the past 5 years.
  • In the past 5 years ALNFL always reported negative operating cash flow.
ALNFL.PA Yearly Net Income VS EBIT VS OCF VS FCFALNFL.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2023 2024 -1M -2M -3M -4M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -50.64%, ALNFL is doing worse than 65.43% of the companies in the same industry.
  • ALNFL has a Return On Equity of -84.25%. This is comparable to the rest of the industry: ALNFL outperforms 49.38% of its industry peers.
Industry RankSector Rank
ROA -50.64%
ROE -84.25%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALNFL.PA Yearly ROA, ROE, ROICALNFL.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2023 2024 -50 -100 -150 -200

1.3 Margins

  • ALNFL does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALNFL.PA Yearly Profit, Operating, Gross MarginsALNFL.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, ALNFL has more shares outstanding
  • ALNFL has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for ALNFL has been reduced compared to a year ago.
ALNFL.PA Yearly Shares OutstandingALNFL.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2023 2024 2M 4M 6M 8M
ALNFL.PA Yearly Total Debt VS Total AssetsALNFL.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2023 2024 1M 2M 3M

2.2 Solvency

  • ALNFL has an Altman-Z score of 4.24. This indicates that ALNFL is financially healthy and has little risk of bankruptcy at the moment.
  • ALNFL's Altman-Z score of 4.24 is fine compared to the rest of the industry. ALNFL outperforms 75.31% of its industry peers.
  • ALNFL has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
  • ALNFL has a better Debt to Equity ratio (0.01) than 79.01% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 4.24
ROIC/WACCN/A
WACCN/A
ALNFL.PA Yearly LT Debt VS Equity VS FCFALNFL.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2023 2024 1M 2M 3M

2.3 Liquidity

  • ALNFL has a Current Ratio of 2.35. This indicates that ALNFL is financially healthy and has no problem in meeting its short term obligations.
  • ALNFL has a Current ratio (2.35) which is comparable to the rest of the industry.
  • ALNFL has a Quick Ratio of 2.35. This indicates that ALNFL is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of ALNFL (2.35) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.35
Quick Ratio 2.35
ALNFL.PA Yearly Current Assets VS Current LiabilitesALNFL.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2023 2024 1M 2M 3M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • ALNFL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 54.35%, which is quite impressive.
EPS 1Y (TTM)54.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-423.53%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • ALNFL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 85.12% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-93.75%
EPS Next 2Y-81.43%
EPS Next 3Y85.12%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALNFL.PA Yearly Revenue VS EstimatesALNFL.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2027 5M 10M 15M
ALNFL.PA Yearly EPS VS EstimatesALNFL.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 0.6 -0.6

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • ALNFL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year ALNFL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALNFL.PA Price Earnings VS Forward Price EarningsALNFL.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALNFL.PA Per share dataALNFL.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 -0.2 -0.3

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ALNFL's earnings are expected to grow with 85.12% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-81.43%
EPS Next 3Y85.12%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for ALNFL!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NFL BIOSCIENCES SA

EPA:ALNFL (2/10/2026, 7:00:00 PM)

1.178

+0.01 (+0.86%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.08%
Inst Owner ChangeN/A
Ins Owners17.79%
Ins Owner ChangeN/A
Market Cap14.93M
Revenue(TTM)N/A
Net Income(TTM)-1.83M
Analysts81.82
Price Target2.99 (153.82%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-11.11%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)11.43%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 6.88
P/tB 7.39
EV/EBITDA N/A
EPS(TTM)-0.36
EYN/A
EPS(NY)-0.32
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS0.17
TBVpS0.16
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -50.64%
ROE -84.25%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.35
Quick Ratio 2.35
Altman-Z 4.24
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-423.53%
EPS Next Y-93.75%
EPS Next 2Y-81.43%
EPS Next 3Y85.12%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y34.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-136.84%
EBIT Next 3Y94.59%
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

NFL BIOSCIENCES SA / ALNFL.PA FAQ

Can you provide the ChartMill fundamental rating for NFL BIOSCIENCES SA?

ChartMill assigns a fundamental rating of 2 / 10 to ALNFL.PA.


What is the valuation status of NFL BIOSCIENCES SA (ALNFL.PA) stock?

ChartMill assigns a valuation rating of 1 / 10 to NFL BIOSCIENCES SA (ALNFL.PA). This can be considered as Overvalued.


What is the profitability of ALNFL stock?

NFL BIOSCIENCES SA (ALNFL.PA) has a profitability rating of 0 / 10.


How financially healthy is NFL BIOSCIENCES SA?

The financial health rating of NFL BIOSCIENCES SA (ALNFL.PA) is 5 / 10.